<?xml version="1.0" encoding="UTF-8"?>
<p>While it is still beneficial to perform vaccination in post-secondary dengue situations, the benefit afforded by vaccination will however be maximal after primary infection, preventing the potentially more severe dengue from secondary wild-type DENV infection (for a review see [
 <xref rid="B23-vaccines-08-00174" ref-type="bibr">23</xref>]). In any case, it will not be required when performing pre-vaccination serological screening to determine whether a positive anti-DENV IgG signal indicates prior primary or post-primary infections. 
</p>
